Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

555 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hsp90 as a therapeutic target in prostate cancer.
Solit DB, Scher HI, Rosen N. Solit DB, et al. Among authors: scher hi. Semin Oncol. 2003 Oct;30(5):709-16. doi: 10.1016/s0093-7754(03)00346-4. Semin Oncol. 2003. PMID: 14571418 Review.
A reappraisal of the role of prophylactic cranial irradiation in limited small cell lung cancer.
Rosenstein M, Armstrong J, Kris M, Shank B, Scher H, Fass D, Harrison L, Fuks Z, Leibel S. Rosenstein M, et al. Int J Radiat Oncol Biol Phys. 1992;24(1):43-8. doi: 10.1016/0360-3016(92)91019-j. Int J Radiat Oncol Biol Phys. 1992. PMID: 1324901 Clinical Trial.
Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer.
Seidman AD, Scher HI, Petrylak D, Dershaw DD, Curley T. Seidman AD, et al. Among authors: scher hi. J Urol. 1992 Mar;147(3 Pt 2):931-4. doi: 10.1016/s0022-5347(17)37426-8. J Urol. 1992. PMID: 1371564 Clinical Trial.
Therapeutic alternatives for hormone-refractory prostatic cancer.
Scher HI, Curley T, Yeh S, Iversen JM, O'Dell M, Larson SM. Scher HI, et al. Semin Urol. 1992 Feb;10(1):55-64. Semin Urol. 1992. PMID: 1373515 Review.
Prostatic cancer: are we closer to rational treatment selection?
Scher HI. Scher HI. Curr Opin Oncol. 1992 Jun;4(3):442-54. Curr Opin Oncol. 1992. PMID: 1379831 Review.
Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy.
Zelefsky MJ, Scher HI, Krol G, Portenoy RK, Leibel SA, Fuks ZY. Zelefsky MJ, et al. Among authors: scher hi. Cancer. 1992 Nov 1;70(9):2319-25. doi: 10.1002/1097-0142(19921101)70:9<2319::aid-cncr2820700918>;2-8. Cancer. 1992. PMID: 1394060
Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression.
Motzer RJ, Nanus DM, O'Moore P, Scher HI, Bajorin DF, Reuter V, Tong WP, Iversen J, Louison C, Albino AP, et al. Motzer RJ, et al. Among authors: scher hi. Cancer Res. 1992 Oct 15;52(20):5775-9. Cancer Res. 1992. PMID: 1394202 Clinical Trial.
Systemic chemotherapy in regionally advanced bladder cancer. Theoretical considerations and results.
Scher HI. Scher HI. Urol Clin North Am. 1992 Nov;19(4):747-59. Urol Clin North Am. 1992. PMID: 1441029 Review.
Prognostic factors for survival of patients with bidimensionally measurable metastatic hormone-refractory prostatic cancer treated with single-agent chemotherapy.
Petrylak DP, Scher HI, Li Z, Myers CE, Geller NL. Petrylak DP, et al. Among authors: scher hi. Cancer. 1992 Dec 15;70(12):2870-8. doi: 10.1002/1097-0142(19921215)70:12<2870::aid-cncr2820701225>;2-f. Cancer. 1992. PMID: 1451069
Chemotherapy for urothelial tract malignancies: breaking the deadlock.
Scher HI, Norton L. Scher HI, et al. Semin Surg Oncol. 1992 Sep-Oct;8(5):316-41. doi: 10.1002/ssu.2980080511. Semin Surg Oncol. 1992. PMID: 1462103 Review.
555 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page